Copertina

Spillover effects of a nudge‐based dietary intervention on physical activity and sleep among adults with type 2 diabetes: Evidence from a randomised controlled trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xiaojing Guo, Tianxue Long, Lang Peng, Yiyun Zhang, Yi Wu, Yating Zhang, Jing Huang, Hua Jiang, Dan Luo, Xue Cai, Rongsong Tang, Dan Zhang, Ran Xin, Mingzi Li
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Diabetes, Obesity and Metabolism
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Nutrition interventions for anxiety, depression, stress and/or diabetes‐related distress in individuals with diabetes: A systematic review and meta‐analysis of randomised controlled trials
di: Prudence I. Morrissey, et al.
Pubblicazione: (2026)

Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials
di: Mengyun Lei, et al.
Pubblicazione: (2025)

Impact of intermittent fasting on self‐regulatory behaviour and sleep in participants with insulin‐treated type 2 diabetes: A secondary analysis of the INTERFAST‐2 randomised controlled trial
di: Anna Ramirez‐Obermayer, et al.
Pubblicazione: (2026)

Rationale and design of a parallel randomised trial of a plant‐based intensive lifestyle intervention for diabetes remission: The REmission of diabetes using a PlAnt ‐based weight loss InteRvention ( REPAIR ) trial
di: Brighid McKay, et al.
Pubblicazione: (2026)

Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial
di: Nan Yu, et al.
Pubblicazione: (2025)

Ultra‐processed food consumption among adults with prediabetes and diabetes, 2001‐2018
di: Zijing Guo, et al.
Pubblicazione: (2025)

Early versus late initiation of long‐acting insulin in paediatric and adult diabetic ketoacidosis: A systematic review and meta‐analysis of randomised control trials
di: Bachviet Nguyen, et al.
Pubblicazione: (2026)

Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial
di: Roman Drai, et al.
Pubblicazione: (2025)

An internet‐based platform with a low‐calorie dietary intervention improves cardiometabolic risk factors in overweight and obese people in China: Half‐year follow‐up results of a randomized controlled trial
di: Yang Zhong, et al.
Pubblicazione: (2024)

Psychosocial outcomes among adults with type 1 diabetes using a tubeless automated insulin delivery system compared with sensor augmented pump therapy: A randomised, parallel‐group clinical trial sub‐study
di: Jean‐Pierre Riveline, et al.
Pubblicazione: (2026)

Development of a predictive model for gastrointestinal side effects of metformin treatment in Chinese individuals with type 2 diabetes based on four randomised clinical trials
di: Weihao Wang, et al.
Pubblicazione: (2024)

Trajectories of body mass index and diabetes mellitus risk among elderly Chinese adults: A 10‐year longitudinal study
di: Yan Guo, et al.
Pubblicazione: (2025)

Changes to insulin requirements over time with semaglutide in adults with type 1 diabetes on insulin pump therapy: A post‐hoc analysis of a double‐blinded, randomised, crossover trial
di: Melissa‐Rosina Pasqua, et al.
Pubblicazione: (2025)

Association of normal range of urinary albumin‐to‐creatinine ratio with all‐cause mortality among diabetic adults with preserved kidney function: National Health and Nutrition Examination Survey ( NHANES ) 2003–2018
di: Xiaoxia Pang, et al.
Pubblicazione: (2025)

Impact of tirzepatide treatment on participant‐reported food craving and food preference: Secondary analyses of a phase 1 randomised controlled trial in people with obesity with dietary restriction
di: Sam F. Kennedy, et al.
Pubblicazione: (2025)

Continuous glucose monitoring in noninsulin‐treated type 2 diabetes: A critical review of reported trials with an updated systematic review and meta‐analysis of randomised controlled trials
di: Ronnie Aronson, et al.
Pubblicazione: (2025)

Comparison of pharmacodynamics and pharmacokinetics of ultra‐rapid‐acting insulin aspart and rapid‐acting insulin aspart around continuous moderate intensity exercise in adults with type 1 diabetes: A randomised controlled trial
di: Jason P. Pitt, et al.
Pubblicazione: (2026)

Comparative effectiveness of continuous positive airway pressure and glucagon‐like peptide‐1 receptor agonists in obstructive sleep apnea: A network meta‐analysis of randomised trials
di: Gaspar R. Chiappa, et al.
Pubblicazione: (2026)

Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
di: Rui Sun, et al.
Pubblicazione: (2025)

Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials
di: Kitti Thammakosol, et al.
Pubblicazione: (2025)

Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus—Results from a randomised controlled trial
di: Emilie S. Andersen, et al.
Pubblicazione: (2025)

Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal‐bolus insulin therapy: A randomised controlled trial
di: Ilaria Dicembrini, et al.
Pubblicazione: (2026)

Impact of eligibility for diabetes remission on response to intensive lifestyle intervention in overweight and obese people with type 2 diabetes: The Look AHEAD trial
di: Joanna Y. Gong, et al.
Pubblicazione: (2025)

Associations between obesity indices and cognitive function: Evidence from a middle‐aged observational and Mendelian randomisation study
di: Sisi Luan, et al.
Pubblicazione: (2025)

Correction to ‘Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta‐analysis of randomised controlled trials’
Pubblicazione: (2026)

Semaglutide and cardiovascular risk in type 1 diabetes: A predictive modelling analysis in a double‐blind, randomised, placebo‐controlled cross‐over trial
di: Luxcia Kugathasan, et al.
Pubblicazione: (2026)

Efficacy and safety of continuous glucose monitoring on glycaemic control in patients with chronic pancreatitis and insulin‐treated diabetes: A randomised, open‐label, crossover trial
di: Line Davidsen, et al.
Pubblicazione: (2025)

Real‐world predictors of progression to type 2 diabetes among adults with prediabetes
di: Tyler Dunn, et al.
Pubblicazione: (2026)

SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST , a novel, decentralised, register‐based randomised trial on prevention of diabetic complications
di: Jan W. Eriksson, et al.
Pubblicazione: (2025)

A preliminary randomized trial of a brief dissonance‐based type 2 diabetes prevention programme for adults with pre‐diabetes
di: Eric Stice, et al.
Pubblicazione: (2025)

Single versus repeat diabetes testing in older adults: Observations from the STAREE clinical trial
di: Jia Yong Tan, et al.
Pubblicazione: (2026)

Burden of type 2 diabetes mellitus and risk factor attribution among older adults: A global, regional, and national analysis from 1990 to 2021, with projections up to 2040
di: Liangquan Lin, et al.
Pubblicazione: (2025)

Dapagliflozin restores odour‐induced functional integration of primary olfactory cortex circuit but not olfactory‐related regional brain activation in patients with type 2 diabetes: A 16‐week randomised comparative study
di: Xin Li, et al.
Pubblicazione: (2025)

Comparative prognostic value of nine cardiorenal biomarkers for mortality among adults with prediabetes and diabetes
di: Chunyan Chai, et al.
Pubblicazione: (2026)

Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation
di: Xue Tian, et al.
Pubblicazione: (2026)

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial
di: Da Hea Seo, et al.
Pubblicazione: (2025)

Efficacy and safety of imeglimin add‐on to DPP ‐4 inhibitor therapy in Japanese patients with type 2 diabetes mellitus: An interim analysis of the randomised, double‐blind FAMILIAR trial
di: Kohei Kaku, et al.
Pubblicazione: (2025)

Efficacy and safety of glucagon‐like peptide 1 receptor agonists across all health outcomes in type 2 diabetes: An umbrella review and evidence map of randomised controlled trials
di: Dongjin Yeo, et al.
Pubblicazione: (2025)

The effect of altered sleep timing on glycaemic outcomes: Systematic review of human intervention studies
di: Romy Slebe, et al.
Pubblicazione: (2024)

Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes ( RACELINES ): A randomised, double‐blind trial
di: Michaël J. B. van Baar, et al.
Pubblicazione: (2025)